RAK Hospital dermatologist explains why even mild winters can aggravate inflammatory skin conditions and how residents can protect their skin
18 December 2025; Ras Al Khaimah, UAE: Dermatologists across the UAE are reporting a seasonal rise in skin-related complaints as winter sets in, with flare-ups of inflammatory conditions such as eczema and psoriasis becoming increasingly common despite the country’s relatively mild temperatures.
The company’s 1st MEA subsidiary positions it at the heart of one of the world’s fastest-growing healthcare regions, enhancing access to trusted, high-quality treatments.
Dubai, United Arab Emirates. 17 December 2025. Greek pharmaceuticals manufacturer, ELPEN, today announced the launch of its 1st MEA subsidiary in the United Arab Emirates. The move marks a major milestone in the company’s international expansion strategy and strengthens its long-term commitment to improving healthcare across the region.
With its new offices in the UAE, ELPEN’s MEA subsidiary will serve as the company’s regional strategic centre, enabling closer engagement with health authorities, clinicians, scientific communities, medical societies, and institutional partners across the region.
Theodore Tryfon, Co – Chief Executive Officer ELPEN Group mentioned: “ELPEN enters the UAE carrying a legacy of nearly six decades of Greek scientific innovation and reliable pharmaceutical manufacturing. By connecting this heritage with a nation investing decisively in world-class healthcare, we aim to build long-term collaborations that support patient access, research excellence and sustainable industry growth. As one of Greece’s most advanced pharmaceutical groups, we remain committed to high-quality production and strong R&D, ensuring that Greek medicines can serve as credible, innovation-driven partners to the UAE’s healthcare vision.”
With the region experiencing rising demand for safe, trusted, and high-quality medicines, the new subsidiary positions ELPEN to operate with greater agility, cultural understanding, and proximity to the needs of local healthcare systems. The company has appointed Mohammad Allakany as General Manager for Middle East and Africa, bringing decades of healthcare experience and a proven leadership track record. In his role, he will oversee ELPEN’s growth strategy and regional expansion across MEA.
Partnership transforms HealthPlus IVF & Women’s Health in the UAE capital
Abu Dhabi, United Arab Emirates; 16 December 2025: Olive Rock Partners (ORP), a leading growth-oriented investor in the Gulf healthcare sector, today announces a strategic collaboration with Cedro Strategy, a specialist healthcare advisory and transformation firm, to accelerate the expansion and evolution of HealthPlus IVF & Women’s Health Abu Dhabi. This partnership represents a significant step in advancing clinical excellence and operational innovation within one of the region’s most dynamic medical markets.
Rayan Salam, Founder & CEO of Cedro Strategy
This collaboration builds on the recent strategic realignment announced earlier this year between Olive Rock Partners and global healthcare platform M42, under which ORP assumed full ownership of HealthPlus IVF & Women’s Health Abu Dhabi. That transaction has set the stage for new investment, specialized focus, and transformative growth in fertility services in the UAE.
Abdullah Shahin, Founding Partner at Olive Rock Partners
Community Initiative Offers Free, Twice-Monthly Coffee Mornings to Bring Comfort, Connection and Expert Guidance to Women — Providing a Safe and Supportive Space
15 December 2025; Dubai, UAE — Orchid Fertility Clinic has announced the launch of its Fertility Support Group, an in-person community initiative designed to offer women a safe, gentle and non-judgmental space to connect, share, and receive emotional and professional support as they navigate the challenges of infertility.
Anne-Sophie Martial, Clinical Psychologist at Orchid Fertility
Dubai, December 11, 2025 — For thousands of UAE residents, the slow crawl between Dubai and Sharjah has become an unavoidable part of daily life. But medical experts caution that the long hours spent sitting in traffic may be doing more harm than many commuters realise. According to leading knee specialist Dr. Azam Badar Khan, widely known as Dr. Knee, the prolonged immobility caused by bumper-to-bumper traffic is contributing to a rise in early knee pain, stiffness, and premature joint degeneration among regular drivers.